Merck & Co. (MRK) is a pharmaceuticals company in the Health Care sector. Listed on the NASDAQ, Merck & Co. is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $119.09.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $119.09 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 14.93% |
| Risk / Std Dev (Annualized) | 23.67% |
| Sharpe Ratio (rf=4.5%) | 0.44 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 14.93% with an annualized volatility of 23.67%. The Sharpe ratio of 0.44 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 294.13B |
| Enterprise Value | 337.6B |
| Trailing P/E | 33.55 |
| Forward P/E | 12.45 |
| Price to Book | 6.41 |
| Price to Sales | 4.47 |
| EV/Revenue | 5.13 |
| EV/EBITDA | 11.44 |
| Profitability | | | Profit Margin | 13.59% | | Operating Margin | 38.6% | | ROE | 18.94% | | ROA | 12.58% |
| Growth | | | Revenue Growth | 4.9% |
| Dividend | | | Dividend Yield | 285.0% | | Payout Ratio | 93.52% | | 5Y Avg Yield | 301.0% |
| Financial Health | | | Total Revenue | 65.77B | | Total Debt | 49.12B | | Total Cash | 5.7B | | Free Cash Flow | 14.05B | | Operating Cash Flow | 17.89B |
| Price & Technical | | | 52W High | $125.14$ | | 52W Low | $76.66$ | | 50-Day Avg | $116.19$ | | 200-Day Avg | $104.27$ | | Beta | 0.22 | | Shares Outstanding | 2.47B | | Float Shares | 2.47B | | Insider Holdings | 0.06% | | Institutional Holdings | 82.3% | | Short Ratio | 3.28 | | Short % of Float | 1.24% |
| Analyst Targets | | | Target High | $150.0$ | | Target Low | $100.0$ | | Target Mean | $129.74$ | | Target Median | $135.0$ | | # of Analysts | 27 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.